Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study

Kristina Jenei, Associate Editor at the Journal of Cancer Policy, shared on X/Twitter:

“New original research led by the extraordinary Khalid El Bairi published in Journal of Clinical Oncology.

Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study.”

Source: Kristina Jenei/X

Khalid El Bairi, founder of The Cancer Biomarkers Working Group, specializes in clinical and translational research in medical oncology.

With many peer-reviewed articles, he delves into predictive and prognostic cancer biomarkers, especially for digestive and gynecological cancers like ovarian and colorectal malignancies.

El Bairi holds board positions in international scientific societies such as IGCS, ESMO, ASCO, ESGO, and AACR. Serving as editor and reviewer for over 40 journals, he also educates medical and Ph.D. students on evidence-based medicine, research methodologies, and publishing ethics.